Callender Dermatology and Cosmetic Center
Dermatology
Dr. Valerie D. Callender, MD
Valerie D. Callender, MD is an expert in the field of Dermatology. She researched medicine at Howard University College of Medicine. She over the years received 3 awards: "Super Doctor", "Fellow (FASDS)" and "Fellow (FAAD)". Valerie Callender is also published. She has 27 publications published. The lastest publication: "Hair Transplantation in the Surgical Treatment of Central Centrifugal Cicatricial Alopecia.' Valerie D. Callender, MD accepts Medicare payments and is listed with Medicare.gov.
Publications
- Hair Transplantation in the Surgical Treatment of Central Centrifugal Cicatricial Alopecia.
- Advances and Challenges in Hair Restoration of Curly Afrocentric Hair.
- A double-blind, randomized, multicenter, controlled trial of suspended polymethylmethacrylate microspheres for the correction of atrophic facial acne Scars.
- Understanding the burden of adult female acne.
- A Multicenter Study of the Safety and Effectiveness of Hyaluronic Acid with a Cohesive Polydensified Matrix for Treatment of Nasolabial Folds in Subjects with Fitzpatr...
- Efficacy and Safety of Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel for the Treatment of Acne and Acne-induced Post-inflammatory Hyperpigmentation in Patients w...
- Prevalence and etiology of central centrifugal cicatricial alopecia.
- Aesthetic Dermatology for Aging Ethnic Skin.
- Hair Transplantation Technique: A Flexible Blade for Preparing Curly Hair Grafts.
- A Meta-analysis to Investigate the Relation Between Fitzpatrick Skin Types and Tolerability of Adapalene-Benzoyl Peroxide Topical Gel in Subjects with Mild or Moderate...
- Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in Skin of color.
- A review of acne in ethnic Skin: pathogenesis, clinical manifestations, and management strategies.
- Safety of nonanimal stabilized hyaluronic acid dermal fillers in patients with Skin of color: a randomized, evaluator-blinded comparative trial.
- Postinflammatory hyperpigmentation: evolving combination treatment strategies.
- Combining clindamycin 1%-benzoyl peroxide 5% gel with multiple therapeutic options.
- Considerations for treating acne in ethnic Skin.
- An open label study of clobetasol propionate 0.05% and betamethasone valerate 0.12% foams in the treatment of mild to moderate acne Keloidalis.
- Topical tazarotene in acne vulgaris: treatment approaches.
- Acne in ethnic Skin.
- Postinflammatory hyperpigmentation: etiologic and therapeutic considerations.
- Central Hair loss in African American women: incidence and potential risk factors.
- Acne in ethnic Skin: special considerations for therapy.
- Medical and surgical therapies for alopecias in black women.
- Tazarotene cream for postinflammatory hyperpigmentation and acne vulgaris in darker Skin: a double-blind, randomized, vehicle-controlled study.
- The effect of vehicle formulation on acne medication tolerability.
- Central scalp alopecia photographic scale in African American women.
Schools
Procedures Preformed
- Destruction of Benign Skin Lesion
Conditions Treated
- Athlete's Foot
- Atopic Dermatitis (Eczema)
- Benign Skin Lesion
- Boil (incl. Carbuncle)
- View All
Doctors Specialties
Accepted Insurances
Awards
- Super Doctor
- Fellow (FASDS)
- Fellow (FAAD)
Education
-
Howard University
-
Howard University College of Medicine
Hospital
-
MedStar Washington Hospital Center
Drug Facts
| NPI NUMBER |
|
1245389717 |
| NPPES Provider LastName |
|
CALLENDER |
| NPPES Provider FirstName |
|
VALERIE |
| NPPES Provider ZIPCode |
|
207699182 |
| NPPES Provider State |
|
MD |
| Specialty Description |
|
Dermatology |
| Total Claim Count |
|
306.0 |
| Distinct Opioid Count |
|
0.0 |
| Opioid Claim Count |
|
0.0 |
| Percent Opioid Claims |
|
0.0 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
| National Provider Identifier [NPI] |
1245389717 |
| Last Name Of The Provider |
CALLENDER |
| First Name Of The Provider |
VALERIE |
| View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog
